| |
|
|
| |
|
|
 Issue
017 |
|
The
higher you climb
Pharmatest services
Getting pharmaceutical research right at the preclinical
stage saves time and money by highlighting problems
early in the process. Pharmatest believes that choosing
the right preclinical partner can help make your
preclinical tests more predictive, and ultimately
cut down on attrition. more... |
| |
|
|
| |
The
best of both worlds
Medicillon/MPI Pre-clinical research
Medicilon/MPI Preclinical Research-Shanghai, a joint
venture between US-based MPI Research and Chinese
company Shanghai Medicilon, is committed to providing
Sponsors quality research in an Asian facility that
meets worldwide regulatory standards. more... |
|
| |
|
|
| |
A
leader in oncology
Oncology services
Oncology Services (OS) is a leading, internationally
operating CRO with unmatched expertise and extensive
experience in oncology drug development and study
management. more... |
|
| |
|
|
|
 Issue
015 |
|
No-danger
development
Medicilon/MPI Preclinical
Research-Shanghai
Accurate decision-making is crucial when it comes
to product development and the risks involved can
be huge. A new venture offers extensive research
and testing facilities dedicated to minimising problems
in preclinical drug discovery. more...
|
| |
|
| |
Optimising
CNS drug availability
Sovicell
Designing pharmaceutical agents so that they pass
the blood-brain barrier and are freely available
to interact with receptors is one of the great challenges
in CNS drug development. An easy-to-use toolkit
has been developed to help overcome this hurdle.
more... |
| |
|
| |
Get
the most from development
Quotient Bioresearch
Early-phase trials are critical to the production
of pharmaceutical products. With a 40-year history
in science, Quotient Bioresearch offers a comprehensive
range of services dedicated to excellence in drug
discovery and development. more...
|
| |
|
| |
One
biomarker at a time
Quest Diagnostics
New technologies are driving the integration of
the next-generation of biomarkers into clinical
trials. Quest Diagnostics provides differentiated
biomarker assays, accelerating clinical research
programmes through its assay development and laboratory
management services. more...
|
| |
|
| |
Quantitative
tissue biomarker analysis
Biovays
From target discovery through to FDA approval, quantitative
biomarker analysis streamlines drug development
and boosts drug approval success rates. more...
|
| |
|
| |
Toxicology
studies
ETS Nederland
Experimental Toxicology Services (ETS) Nederland
BV, based in Zutphen, Netherlands, is a privately
owned toxicology consultancy managed by Henk Tennekes,
PhD. ETS ensures high quality monitoring of outsourced
toxicology studies in close collaboration with study
sponsors, usually R&D departments of pharmaceutical
and biotech companies.
more... |
| |
|
| |
Simple
decapping
Hamilton Bonaduz
Tired of manually opening and closing screw-cap
tubes? The new Hamilton DeCapper for screw-cap tubes
will take care of this awkward and time-consuming
task while you use your time for more interesting
activities. more...
|
| |
Global
laboratory services
Eurofins Medinet
Eurofins Medinet is a global organisation dedicated
to providing standardised, high quality, global
central laboratory services to support all phases
of clinical trials. With over 20 years’ experience
and scientific accomplishment, its laboratory testing
portfolio has become one of the widest available
in the biopharmaceutical industry, offering the
synergy of integrating central laboratory services
with bioanalytical, genomic and anti-infective services.
more...
|
|
 Issue
014 |
|
Quality,
safety and reliability
B. Braun
In an increasingly expanding market, pharmaceutical
companies are coming to rely on contract services
providers, such as B. Braun, which offer expertise,
products and services. more...
|
| |
|
| |
Dedicated
outsourcing specialist
Enestia
There are many reasons why pharmaceutical
companies outsource services to contractors, from
complementing manufacturing and packaging processes
tocreating custom-designed added value for the
long-term future. more...
|
| |
|
| |
Strategy
for growth
Nycomed
The dynamic market for contract manufacturing
has seen low-cost countries take on more commoditised
processes. Nycomed, a service provider operating
in mature markets for many years, has refocused
the top end of its market and succeeded through
rapid growth. more...
|
|
 Issue
013 |
|
Comprehensive
therapy safety
B. Braun
Drugs alone do not cure people with illnesses: a
holistic approach to patient health care is required,
from medical devices and procedures to drug delivery
and personal hygiene.
more... |
| |
|
| |
Commitment
to excellence
Nycomed
Pharmaceutical contract manufacturing is a highly
competitive business currently growing by 12% a
year. But there are only a few third-party
manufacturers that can offer capacity supported
by know-how, quality assurance and the ability to
develop a client’s R&D and transform it
into a market product.
more... |
| |
|
| |
Complete
scientific confidence
MPI Research
Contract research organisations provide many services
to pharmaceutical companies to improve production
processes and help gain competitive advantage. For
added value, however, a CRO must prove itself to
be more that just a vendor.
more... |
|
 Issue
012 |
|
Expansion
rewards for all
Grupo Uriach
Integral Contract Services
With new facilities and individually tailored customer
care plans, one Spanish contract manufacturer now
offers an improved service range.
more... |
| |
|
| |
Rules
of attraction
Hameln Pharmaceuticals
Dr Dieter Gothier, managing director of Hameln Pharmaceuticals,
explains to Lorrie Kelly how the company’s
ethos of flexibility, reliability and responsiveness,
combined with its new production facility, will
ensure strong customer allegiance. more... |
|
 Issue
011 |
|
Effective
process chemistry partnering
ROW2 Technologies
During early development of an NCE, process chemists
are charged with finding a commercially viable route
within a time-constrained environment. Following
commercialisation, these scientists move on to the
next blockbuster and justifiably little attention
is devoted to evaluating alternative syntheses that
can cut manufacturing costs. But, through its flagship
service RouteDesign, ROW2 Technologies Inc believes
an invaluable service for process chemists during
route selection is at hand. more... |
| |
|
| |
Search
for added value
hameln pharmaceuticals
To find the right contract manufacturer to make
high-quality products, service providers need to
be evaluated according to an objective catalogue
of criteria, and against subjective factors. Product
quality and low price were always the decisive factors
in selecting a service provider to deal with the
contract manufacture of pharmaceuticals. more... |
| |
|
| |
Escape
cost and hassle
Cenexi
As a production line ages, it becomes incapable
of delivering products that meet current regulatory
requirements. However, it is difficult for many
pharmaceutical companies to justify the huge investment
needed to upgrade or replace it. Outsourcing the
production of injectable ampoules to a specialist
contractor is one of the most efficient and cost-effective
solutions. more... |
| |
|
| |
Partnerships
for innovation
Evotec AG
The pharmaceutical industry faces a stiff challenge
in revitalising the process of drug discovery,
which is perceived to be increasingly under threat.
Blockbuster drugs are coming off patent, investment
in early-stage biotechnology research is diminishing
and the pipeline of new pharmaceutical products
needs to be rapidly refilled. Many pharma and
biotech companies are now looking to develop partnerships
to address these problems, and the signs are that
they are achieving a measure of success. more...
|
| |
|
| |
Next
generation pharma solution
NextPharma
Contract manufacturing has become an essential strategy
for pharmaceutical laboratories. Through a number
of acquisitions, one European company has broadened
its portfolio of services to provide a one-stop
shop for the needs of laboratories worldwide. more... |
|
 Issue
010 |
|
Meeting
the needs of global clinical trials
Quest Diagnostics
Quest Diagnostics is a leading clinical diagnostic
testing company with over 42,000 employees and approximately
$6bn in yearly revenues. The clinical trials business
within Quest Diagnostics consists of over 500 dedicated
employees providing central laboratory testing to
support global Phase II–IV clinical trials.
more... |
| |
|
| |
Delivering
Therapeutic Foresight And Results
INC Research
With a long-standing history of therapeutic speciality
and technological innovation, one company has transformed
itself from a start-up contract research organisation
into a drug development leader specialising in oncology,
CNS and paediatrics, with full data services capabilities.
more... |
| |
|
| |
The
art of organic synthensis
Syncom BV
Despite the pace of technology, the human touch
is necessary when it comes to specialist areas.
Organic synthesis is a complex field requiring expert
knowledge and the experience to know what will work.
more... |
| |
|
| |
Taiwan's
centre of innovation
The Development Center
for Biotechnology (DCB)
The Development Center for Biotechnology
has done much to support its country’s biotech
industry. The organisation has recently stepped
up its activities to act as a bridge to the international
community. more... |
| |
|
| |
Outsourcing
production reduces costs
Cenexi
With drug producers under great pressure
to reduce prices, one contract manufacturer argues
that the industry should consider contracting out
at least some of its production. more... |
| |
|
| |
The
challenges and benefits of biomarkers
BioProof AG
The development costs for new drugs
are rapidly and constantly increasing. Since most
pharmaceutical companies are already pushing timelines
as hard as possible, it is not possible to reduce
costs by shortening the non-clinical and clinical
programmes. more... |
|
 Issue
009 |
|
Evaluating
ozonolysis
KNC Laboratories Co Ltd
Sota Kurita of KNC Laboratories Co Ltd explores
the pros and cons of using ozonolysis in pharmaceutical
process development. more...
|
| |
|
| |
The
biomedical heart of Scandinavia
Business Region Göteborg
Göteborg, Scandinavia’s most expansive
pharma cluster, offers space for institutions, organisations
and businesses with ties to biomedical research
and development. more... |
| |
|
| |
PMBs
at the crossroads
Medicago, Inc
After several early problems, plant-made biopharmaceuticals
are once again attracting attention. Technologies
developed by a new generation of biotech companies
could help the market achieve commercial maturity,
writes Frédéric Ors. more... |
| |
|
| |
Clinical
testing and bioanalytical services
Mitsubishi Kagaku Bio-Clinical
Laboratories
Established in 1988, Mitsubishi
Kagaku Bio-Clinical Laboratories (MBC) has nearly
20 years’ experience of clinical testing and
drug development supporting services in Japan. more...
|
|
 Issue
008 |
|
Related
articles from this issue |
| |
|
| |
 The
emergence of virtual screening
High throughput screening of large collections
of chemical compounds remains an important step
in many drug discovery research projects. Jin Li
and Timothy Lovell, Chemical Computing, AstraZeneca,
review the complementary virtual screening methodologies.
|
| |
|
| |
Is
there a mux up?
Nicholas Westwood, University of St
Andrews, and Graham Smith, Pfizer Global
R&D, discuss the technology associated
with the analysis of crude reaction mixtures. more.. |
|
 Issue
007 |
|
Targeting
peptides
Karyon Ltd
Karyon Ltd’s operations focus on
the discovery, IP protection and early development
of carrier peptides that target specific tissues...
more.. |
| |
|
| |
Biotechnology
partnerships
BioTie Therapies
Biotie Therapies is a drug development biotechnology
company with a focus on dependence disorders, inflammatory
diseases and thrombosis...
click
here for more |
| |
|
| |
The
growing pull of peptides
Peptisyntha SA
Demand for peptide APIs is now centred on large
quantities of custom-made and complex peptides,
and specialist producers are seeing a window of
opportunity... more.. |
